Association Between Hormone Receptor Expression and Epidermal Growth Factor Receptor Mutation in Patients Operated on for Non-Small Cell Lung Cancer
- 1 May 2011
- journal article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 91 (5), 1562-1567
- https://doi.org/10.1016/j.athoracsur.2011.02.001
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR MutationClinical Cancer Research, 2009
- Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancerLung Cancer, 2009
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular TrendsJournal of Thoracic Oncology, 2008
- Aromatase Expression Predicts Survival in Women with Early-Stage Non–Small Cell Lung CancerCancer Research, 2007
- Lung cancer in never smokers — a different diseaseNature Reviews Cancer, 2007
- Aromatase Inhibitors in Human Lung Cancer TherapyCancer Research, 2005
- Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Progesterone Receptor in Non–Small Cell Lung Cancer—A Potent Prognostic Factor and Possible Target for Endocrine TherapyCancer Research, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004